DK0850243T3 - O-Glycaninhibitorer af selectinmedieret inflammation - Google Patents

O-Glycaninhibitorer af selectinmedieret inflammation

Info

Publication number
DK0850243T3
DK0850243T3 DK96928073T DK96928073T DK0850243T3 DK 0850243 T3 DK0850243 T3 DK 0850243T3 DK 96928073 T DK96928073 T DK 96928073T DK 96928073 T DK96928073 T DK 96928073T DK 0850243 T3 DK0850243 T3 DK 0850243T3
Authority
DK
Denmark
Prior art keywords
glycans
selectin
glycan
beta
disialylated
Prior art date
Application number
DK96928073T
Other languages
English (en)
Inventor
P Mcever Rodger
D Cummings Richard
L Moore Kevin
Original Assignee
Univ Oklahoma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Oklahoma filed Critical Univ Oklahoma
Application granted granted Critical
Publication of DK0850243T3 publication Critical patent/DK0850243T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
    • C07H3/06—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70596—Molecules with a "CD"-designation not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52—Genes encoding for enzymes or proenzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Plant Pathology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK96928073T 1995-08-03 1996-08-02 O-Glycaninhibitorer af selectinmedieret inflammation DK0850243T3 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US51092095A 1995-08-03 1995-08-03
US1779496P 1996-05-15 1996-05-15
US64980296A 1996-05-17 1996-05-17
PCT/US1996/012820 WO1997006176A2 (en) 1995-08-03 1996-08-02 Peptide and o-glycan inhibitors of selectin mediated inflammation

Publications (1)

Publication Number Publication Date
DK0850243T3 true DK0850243T3 (da) 2004-02-02

Family

ID=27360885

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96928073T DK0850243T3 (da) 1995-08-03 1996-08-02 O-Glycaninhibitorer af selectinmedieret inflammation

Country Status (11)

Country Link
EP (1) EP0850243B1 (da)
JP (1) JPH11510543A (da)
KR (1) KR100523506B1 (da)
AT (1) ATE251636T1 (da)
AU (1) AU723262B2 (da)
CA (1) CA2228512A1 (da)
DE (1) DE69630307T2 (da)
DK (1) DK0850243T3 (da)
ES (1) ES2208759T3 (da)
MX (1) MXPA98000968A (da)
WO (1) WO1997006176A2 (da)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6277975B1 (en) 1992-10-23 2001-08-21 Genetics Institute, Inc. Fusions of P-selectin ligand protein and polynucleotides encoding same
MXPA00012586A (es) * 1998-06-16 2004-05-21 Univ Oklahoma Glicosulfopeptidos y metodos de sintesis y uso de los mismos.
US7223845B2 (en) 1998-06-16 2007-05-29 The Board Of Regents Of The University Of Oklahoma Synthetic glycosulfopeptides and methods of synthesis thereof
US20030143662A1 (en) 1998-06-16 2003-07-31 Cummings Richard D. Glycosulfopeptide inhibitors of leukocyte rolling and methods of use thereof
JP2002528513A (ja) * 1998-10-30 2002-09-03 ジェネティックス・インスチチュート・インコーポレーテッド Ｐ−セレクチンリガンド（ｐｓｇｌ）アンタゴニストによる細胞毒性ｔ−細胞分化の阻害
AU1629700A (en) * 1998-11-21 2000-06-13 Regents Of The University Of California, The Use of core 2 glcnac transferase inhibitors in treating inflammation
US6492152B1 (en) 1999-06-15 2002-12-10 The Board Of Regents Of The University Of Oklahoma Core 1 β3-galactosyl transferases and methods of use thereof
US7256171B1 (en) 1999-11-20 2007-08-14 The Regents Of The University Of California Use of core 2 G1cNAc transferase inhibitors in treating inflammation
EP1325123A4 (en) * 2000-09-12 2004-07-21 Inst Genetics Llc STENOSE- OR RESEARCH INHIBITION BY P-SELECTIN ANTAGONISTS
CA2433225A1 (en) * 2000-12-29 2002-07-11 Bio-Technology General, Inc. Isolated molecules comprising epitopes containing sulfated moieties, antibodies to such epitopes, and uses thereof
US20040116333A1 (en) 2001-08-03 2004-06-17 Rong-Hwa Lin Modulators of P-selectin glycoprotein ligand 1
US7744888B2 (en) 2001-08-03 2010-06-29 Abgenomics Cooperatief U.A. Methods of modulating T cell or natural killer cell activity with anti-P-selectin glycoprotein ligand 1 antibodies
WO2004012817A2 (en) * 2002-07-31 2004-02-12 Kylix B.V. Use of genes identified to be involved in tumor development for the development of anti-cancer drugs
JP4599027B2 (ja) * 2002-10-30 2010-12-15 東洋水産株式会社 Ｌ−セレクチン結合阻害剤
FI20021989A0 (fi) * 2002-11-06 2002-11-06 Halina Miller-Podraza Korkean affiniteetin Helicobacter pylori-reseptorit ja niiden käyttö
US20080182801A1 (en) 2003-12-22 2008-07-31 Btg International Limited Core 2 glcnac-t inhibitors
GB0329667D0 (en) 2003-12-22 2004-01-28 King S College London Core 2 GlcNAc-T inhibitor
GB0513881D0 (en) 2005-07-06 2005-08-10 Btg Int Ltd Core 2 GLCNAC-T Inhibitors III
MY148646A (en) 2004-05-10 2013-05-15 Abgenomics Cooperatief Ua Anti-psgl-1 antibodies
NZ551625A (en) 2004-05-11 2011-03-31 Abgenomics Cooperatief Ua T-cell death-inducing epitopes
GB0513883D0 (en) 2005-07-06 2005-08-10 Btg Int Ltd Diagnosis of Atherosclerosis
GB0513888D0 (en) 2005-07-06 2005-08-10 Btg Int Ltd Core 2 GLCNAC-T Inhibitors II
US20070298034A9 (en) * 2005-12-09 2007-12-27 Angela Widom Sulfotyrosine specific antibodies and uses therefor
JP5331293B2 (ja) * 2006-04-28 2013-10-30 公益財団法人野口研究所 多様性を表現するオリゴ糖またはその誘導体
JP6071199B2 (ja) * 2008-09-02 2017-02-01 コンストラクション リサーチ アンド テクノロジー ゲーエムベーハーＣｏｎｓｔｒｕｃｔｉｏｎ Ｒｅｓｅａｒｃｈ ＆ Ｔｅｃｈｎｏｌｏｇｙ ＧｍｂＨ 可塑剤含有硬化促進剤組成物
US20120207737A1 (en) * 2009-10-21 2012-08-16 University Of Zurich Medical utility of glycan-binding proteins and glycans
WO2012174001A1 (en) 2011-06-13 2012-12-20 Abgenomics Cooperatief U.A. Anti-psgl-1 antibodies and uses thereof
US11306150B2 (en) 2017-01-11 2022-04-19 Bristol-Myers Squibb Company Method of identifying a P-selectin glycoprotein ligand-1 (PSGL-1) antagonist
CN110740749A (zh) 2017-03-14 2020-01-31 戊瑞治疗有限公司 在酸性pH下与VISTA结合的抗体

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0668907A1 (en) * 1992-11-16 1995-08-30 Board Of Regents Of The University Of Oklahoma Glycoprotein ligand for p-selectin and methods of use thereof
WO1995030001A2 (en) * 1994-04-28 1995-11-09 Genetics Institute, Inc. Novel p-selectin ligand protein

Also Published As

Publication number Publication date
CA2228512A1 (en) 1997-02-20
WO1997006176A2 (en) 1997-02-20
WO1997006176A3 (en) 1997-07-24
ES2208759T3 (es) 2004-06-16
KR20040039440A (ko) 2004-05-10
AU723262B2 (en) 2000-08-24
EP0850243B1 (en) 2003-10-08
AU6766996A (en) 1997-03-05
ATE251636T1 (de) 2003-10-15
DE69630307D1 (de) 2003-11-13
MXPA98000968A (es) 2002-07-15
EP0850243A2 (en) 1998-07-01
DE69630307T2 (de) 2004-07-15
KR100523506B1 (en) 2005-10-24
JPH11510543A (ja) 1999-09-14

Similar Documents

Publication Publication Date Title
DK0850243T3 (da) O-Glycaninhibitorer af selectinmedieret inflammation
Kenne et al. Structural studies of Shigella flexneri O‐antigens
AU6210698A (en) Carbohydrate mixture
Vieira et al. Structure of a fucose-branched chondroitin sulfate from sea cucumber. Evidence for the presence of 3-O-sulfo-beta-D-glucuronosyl residues
Lamblin et al. Primary structure determination of five sialylated oligosaccharides derived from bronchial mucus glycoproteins of patients suffering from cystic fibrosis. The occurrence of the NeuAc alpha (2----3) Gal beta (1----4)[Fuc alpha (1----3)] GlcNAc beta (1----.) structural element revealed by 500-MHz 1H NMR spectroscopy.
NZ334021A (en) Dietary supplement containing at least two saccharides being the building blocks of glycoproteins
Ray et al. The effect of auxin on synthesis of oat coleoptile cell wall constituents
NZ512751A (en) Fibre blend for enteral composition
MY124548A (en) Synthetic polysaccharides, preparation method therefor and pharmaceutical compositons containing same
Larm et al. The pneumococcal polysaccharides: a re-examination
Klein et al. The broad diversity of neutral and sialylated oligosaccharides derived from human salivary mucins
Wieruszeski et al. Structure of two new oligosaccharides isolated from human milk: sialylated lacto-N-fucopentaoses I and II
KR890014128A (ko) 황산염화된 k5 항원 및 황산염화된 k5 항원 단편물
AU4691285A (en) Membrane polysaccharides
Lloyd et al. Immunochemical studies on blood groups. XXXVII. The structures of difucosyl and other oligosaccharides produced by alkaline degradation of blood group A, B, and H substances. Optical rotatory dispersion and circular dichroism spectra of these oligosaccharides
da Silva et al. Carbohydrate, glycopeptide and protein components of the lichen Sticta sp. and effect of storage
Tsuji et al. The carbohydrate moiety of Band-3 glycoprotein of human erythrocyte membranes
ITMI912310A1 (it) Dermatan solfato ad alto titolo, dotato di elevata attivita' trombolitica, e forme farmaceutiche che lo contengono.
Degroote et al. Sulfated oligosaccharides isolated from the respiratory mucins of a secretor patient suffering from chronic bronchitis
AU3266797A (en) Synthetic polysaccharides, method for preparing same and pharmaceutical compositions containing said polysaccharides
WO1997021416A3 (es) Glicoconjugados de substancias opiaceas
Savage et al. Structural characterization of sialylated tetrasaccharides and pentasaccharides with blood group H and Lex activity isolated from bovine submaxillary mucin
Hellerqvist et al. Structural studies of the O-specific side-chains of the cell-wall lipopolysaccharide from Salmonella senftenberg
Kitajima et al. Analytical methods for identifying and quantitating deamidated sialic acid (2-keto-3-deoxy-d-glycero-d-galactonononic acid) and α2→ 8-linked poly (oligo) nonulosonate residues in glycoconjugates
Rahman et al. The structure of the capsular polysaccharide from a swarming strain of pathogenic Proteus vulgaris